–
Boundless Bio, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.3
FY22:
−46.5
FY23:
−54.8
FY24:
−73.3
FY25:
−63.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.6
FY22:
−45.5
FY23:
−53.8
FY24:
−72.2
FY25:
−62.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.2
FY22:
−45.9
FY23:
−49.4
FY24:
−65.4
FY25:
−58.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.2
FY22:
−45.9
FY23:
−49.4
FY24:
−65.4
FY25:
−58.2
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.